nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—breast cancer—Betamethasone—ankylosing spondylitis	0.449	0.5	CpDpCtD
Prochlorperazine—breast cancer—Dexamethasone—ankylosing spondylitis	0.449	0.5	CpDpCtD
Prochlorperazine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0114	0.216	CbGbCtD
Prochlorperazine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00861	0.164	CbGbCtD
Prochlorperazine—CYP3A4—Betamethasone—ankylosing spondylitis	0.00739	0.14	CbGbCtD
Prochlorperazine—CYP3A4—Prednisolone—ankylosing spondylitis	0.00729	0.139	CbGbCtD
Prochlorperazine—CYP3A4—Prednisone—ankylosing spondylitis	0.00689	0.131	CbGbCtD
Prochlorperazine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.00676	0.129	CbGbCtD
Prochlorperazine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0043	0.0817	CbGbCtD
Prochlorperazine—Pigmentation skin—Prednisone—ankylosing spondylitis	0.00176	0.0361	CcSEcCtD
Prochlorperazine—Megacolon—Methotrexate—ankylosing spondylitis	0.00163	0.0335	CcSEcCtD
Prochlorperazine—Pigmentation disorder—Prednisone—ankylosing spondylitis	0.000962	0.0197	CcSEcCtD
Prochlorperazine—Embolism venous—Prednisolone—ankylosing spondylitis	0.000875	0.018	CcSEcCtD
Prochlorperazine—Embolism venous—Triamcinolone—ankylosing spondylitis	0.000805	0.0165	CcSEcCtD
Prochlorperazine—Embolism venous—Methylprednisolone—ankylosing spondylitis	0.000803	0.0165	CcSEcCtD
Prochlorperazine—Menstruation irregular—Prednisolone—ankylosing spondylitis	0.000798	0.0164	CcSEcCtD
Prochlorperazine—Retinal disorder—Methotrexate—ankylosing spondylitis	0.000751	0.0154	CcSEcCtD
Prochlorperazine—Systemic lupus erythematosus—Triamcinolone—ankylosing spondylitis	0.000734	0.0151	CcSEcCtD
Prochlorperazine—Menstruation irregular—Triamcinolone—ankylosing spondylitis	0.000734	0.0151	CcSEcCtD
Prochlorperazine—Menstruation irregular—Methylprednisolone—ankylosing spondylitis	0.000732	0.015	CcSEcCtD
Prochlorperazine—Embolism venous—Dexamethasone—ankylosing spondylitis	0.00073	0.015	CcSEcCtD
Prochlorperazine—Embolism venous—Betamethasone—ankylosing spondylitis	0.00073	0.015	CcSEcCtD
Prochlorperazine—Menstruation irregular—Dexamethasone—ankylosing spondylitis	0.000666	0.0137	CcSEcCtD
Prochlorperazine—Menstruation irregular—Betamethasone—ankylosing spondylitis	0.000666	0.0137	CcSEcCtD
Prochlorperazine—Embolism venous—Prednisone—ankylosing spondylitis	0.000636	0.0131	CcSEcCtD
Prochlorperazine—Menstruation irregular—Prednisone—ankylosing spondylitis	0.00058	0.0119	CcSEcCtD
Prochlorperazine—Throat sore—Triamcinolone—ankylosing spondylitis	0.000564	0.0116	CcSEcCtD
Prochlorperazine—Oropharyngeal discomfort—Triamcinolone—ankylosing spondylitis	0.000559	0.0115	CcSEcCtD
Prochlorperazine—Mydriasis—Prednisolone—ankylosing spondylitis	0.000554	0.0114	CcSEcCtD
Prochlorperazine—Sudden death—Methotrexate—ankylosing spondylitis	0.000524	0.0108	CcSEcCtD
Prochlorperazine—Glycosuria—Triamcinolone—ankylosing spondylitis	0.000501	0.0103	CcSEcCtD
Prochlorperazine—Glycosuria—Methylprednisolone—ankylosing spondylitis	0.0005	0.0103	CcSEcCtD
Prochlorperazine—Amenorrhoea—Methylprednisolone—ankylosing spondylitis	0.000461	0.00947	CcSEcCtD
Prochlorperazine—Glycosuria—Dexamethasone—ankylosing spondylitis	0.000455	0.00934	CcSEcCtD
Prochlorperazine—Glycosuria—Betamethasone—ankylosing spondylitis	0.000455	0.00934	CcSEcCtD
Prochlorperazine—Oropharyngeal pain—Triamcinolone—ankylosing spondylitis	0.000447	0.00917	CcSEcCtD
Prochlorperazine—Deep vein thrombosis—Methotrexate—ankylosing spondylitis	0.000441	0.00905	CcSEcCtD
Prochlorperazine—Eruption—Methotrexate—ankylosing spondylitis	0.000436	0.00895	CcSEcCtD
Prochlorperazine—Amenorrhoea—Dexamethasone—ankylosing spondylitis	0.00042	0.00861	CcSEcCtD
Prochlorperazine—Amenorrhoea—Betamethasone—ankylosing spondylitis	0.00042	0.00861	CcSEcCtD
Prochlorperazine—Dermatitis contact—Triamcinolone—ankylosing spondylitis	0.000401	0.00824	CcSEcCtD
Prochlorperazine—Glycosuria—Prednisone—ankylosing spondylitis	0.000396	0.00813	CcSEcCtD
Prochlorperazine—Cyanosis—Methotrexate—ankylosing spondylitis	0.000379	0.00778	CcSEcCtD
Prochlorperazine—Amenorrhoea—Prednisone—ankylosing spondylitis	0.000365	0.0075	CcSEcCtD
Prochlorperazine—Dermatitis contact—Dexamethasone—ankylosing spondylitis	0.000364	0.00747	CcSEcCtD
Prochlorperazine—Dermatitis contact—Betamethasone—ankylosing spondylitis	0.000364	0.00747	CcSEcCtD
Prochlorperazine—Increased appetite—Prednisolone—ankylosing spondylitis	0.000341	0.007	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Prednisolone—ankylosing spondylitis	0.000331	0.0068	CcSEcCtD
Prochlorperazine—Apnoea—Methotrexate—ankylosing spondylitis	0.000316	0.00649	CcSEcCtD
Prochlorperazine—Increased appetite—Triamcinolone—ankylosing spondylitis	0.000314	0.00644	CcSEcCtD
Prochlorperazine—Increased appetite—Methylprednisolone—ankylosing spondylitis	0.000313	0.00643	CcSEcCtD
Prochlorperazine—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.000305	0.00626	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.000305	0.00625	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.000304	0.00624	CcSEcCtD
Prochlorperazine—Increased appetite—Betamethasone—ankylosing spondylitis	0.000285	0.00584	CcSEcCtD
Prochlorperazine—Increased appetite—Dexamethasone—ankylosing spondylitis	0.000285	0.00584	CcSEcCtD
Prochlorperazine—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.00028	0.00575	CcSEcCtD
Prochlorperazine—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.00028	0.00574	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.000276	0.00567	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.000276	0.00567	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Methotrexate—ankylosing spondylitis	0.000268	0.00551	CcSEcCtD
Prochlorperazine—Influenza—Triamcinolone—ankylosing spondylitis	0.000255	0.00523	CcSEcCtD
Prochlorperazine—Asthma—Triamcinolone—ankylosing spondylitis	0.000255	0.00523	CcSEcCtD
Prochlorperazine—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.000254	0.00522	CcSEcCtD
Prochlorperazine—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.000254	0.00522	CcSEcCtD
Prochlorperazine—Weight increased—Prednisolone—ankylosing spondylitis	0.000252	0.00518	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.000252	0.00517	CcSEcCtD
Prochlorperazine—Increased appetite—Prednisone—ankylosing spondylitis	0.000248	0.00509	CcSEcCtD
Prochlorperazine—Coma—Methotrexate—ankylosing spondylitis	0.000245	0.00503	CcSEcCtD
Prochlorperazine—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.00024	0.00493	CcSEcCtD
Prochlorperazine—Weight increased—Triamcinolone—ankylosing spondylitis	0.000232	0.00476	CcSEcCtD
Prochlorperazine—Weight increased—Methylprednisolone—ankylosing spondylitis	0.000231	0.00475	CcSEcCtD
Prochlorperazine—Photosensitivity—Methotrexate—ankylosing spondylitis	0.000222	0.00455	CcSEcCtD
Prochlorperazine—Cardiac arrest—Prednisone—ankylosing spondylitis	0.000222	0.00455	CcSEcCtD
Prochlorperazine—Weight increased—Dexamethasone—ankylosing spondylitis	0.00021	0.00432	CcSEcCtD
Prochlorperazine—Weight increased—Betamethasone—ankylosing spondylitis	0.00021	0.00432	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.000209	0.00428	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.000209	0.00428	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.000206	0.00423	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.000201	0.00413	CcSEcCtD
Prochlorperazine—Arrhythmia—Prednisolone—ankylosing spondylitis	0.000198	0.00407	CcSEcCtD
Prochlorperazine—Erythema—Prednisolone—ankylosing spondylitis	0.000193	0.00396	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.000185	0.00381	CcSEcCtD
Prochlorperazine—Weight increased—Prednisone—ankylosing spondylitis	0.000183	0.00376	CcSEcCtD
Prochlorperazine—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.000182	0.00374	CcSEcCtD
Prochlorperazine—Vision blurred—Prednisolone—ankylosing spondylitis	0.000182	0.00373	CcSEcCtD
Prochlorperazine—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.000182	0.00373	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000182	0.00373	CcSEcCtD
Prochlorperazine—Erythema—Triamcinolone—ankylosing spondylitis	0.000178	0.00364	CcSEcCtD
Prochlorperazine—Erythema—Methylprednisolone—ankylosing spondylitis	0.000177	0.00364	CcSEcCtD
Prochlorperazine—Angioedema—Prednisolone—ankylosing spondylitis	0.000176	0.00362	CcSEcCtD
Prochlorperazine—Asthma—Methotrexate—ankylosing spondylitis	0.000168	0.00345	CcSEcCtD
Prochlorperazine—Convulsion—Prednisolone—ankylosing spondylitis	0.000167	0.00343	CcSEcCtD
Prochlorperazine—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000167	0.00342	CcSEcCtD
Prochlorperazine—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000165	0.00339	CcSEcCtD
Prochlorperazine—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000165	0.00339	CcSEcCtD
Prochlorperazine—Angioedema—Triamcinolone—ankylosing spondylitis	0.000162	0.00333	CcSEcCtD
Prochlorperazine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000162	0.00332	CcSEcCtD
Prochlorperazine—Erythema—Dexamethasone—ankylosing spondylitis	0.000161	0.00331	CcSEcCtD
Prochlorperazine—Erythema—Betamethasone—ankylosing spondylitis	0.000161	0.00331	CcSEcCtD
Prochlorperazine—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00016	0.00328	CcSEcCtD
Prochlorperazine—Oedema—Prednisolone—ankylosing spondylitis	0.000158	0.00323	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000158	0.00323	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000155	0.00318	CcSEcCtD
Prochlorperazine—Cough—Triamcinolone—ankylosing spondylitis	0.000155	0.00318	CcSEcCtD
Prochlorperazine—Convulsion—Triamcinolone—ankylosing spondylitis	0.000154	0.00316	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000154	0.00315	CcSEcCtD
Prochlorperazine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000154	0.00315	CcSEcCtD
Prochlorperazine—Drowsiness—Methotrexate—ankylosing spondylitis	0.00015	0.00308	CcSEcCtD
Prochlorperazine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000148	0.00303	CcSEcCtD
Prochlorperazine—Angioedema—Dexamethasone—ankylosing spondylitis	0.000147	0.00302	CcSEcCtD
Prochlorperazine—Angioedema—Betamethasone—ankylosing spondylitis	0.000147	0.00302	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000145	0.00297	CcSEcCtD
Prochlorperazine—Oedema—Triamcinolone—ankylosing spondylitis	0.000145	0.00297	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000145	0.00297	CcSEcCtD
Prochlorperazine—Arrhythmia—Prednisone—ankylosing spondylitis	0.000144	0.00295	CcSEcCtD
Prochlorperazine—Infection—Triamcinolone—ankylosing spondylitis	0.000144	0.00295	CcSEcCtD
Prochlorperazine—Infection—Methylprednisolone—ankylosing spondylitis	0.000144	0.00295	CcSEcCtD
Prochlorperazine—Insomnia—Prednisolone—ankylosing spondylitis	0.000143	0.00293	CcSEcCtD
Prochlorperazine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00014	0.00288	CcSEcCtD
Prochlorperazine—Erythema—Prednisone—ankylosing spondylitis	0.00014	0.00288	CcSEcCtD
Prochlorperazine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00014	0.00287	CcSEcCtD
Prochlorperazine—Convulsion—Dexamethasone—ankylosing spondylitis	0.00014	0.00286	CcSEcCtD
Prochlorperazine—Convulsion—Betamethasone—ankylosing spondylitis	0.00014	0.00286	CcSEcCtD
Prochlorperazine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000135	0.00277	CcSEcCtD
Prochlorperazine—Vision blurred—Prednisone—ankylosing spondylitis	0.000132	0.00271	CcSEcCtD
Prochlorperazine—Oedema—Dexamethasone—ankylosing spondylitis	0.000132	0.0027	CcSEcCtD
Prochlorperazine—Oedema—Betamethasone—ankylosing spondylitis	0.000132	0.0027	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000132	0.0027	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000132	0.0027	CcSEcCtD
Prochlorperazine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000131	0.00269	CcSEcCtD
Prochlorperazine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000131	0.00268	CcSEcCtD
Prochlorperazine—Infection—Dexamethasone—ankylosing spondylitis	0.000131	0.00268	CcSEcCtD
Prochlorperazine—Infection—Betamethasone—ankylosing spondylitis	0.000131	0.00268	CcSEcCtD
Prochlorperazine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000129	0.00265	CcSEcCtD
Prochlorperazine—Agitation—Prednisone—ankylosing spondylitis	0.000129	0.00265	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000129	0.00264	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000129	0.00264	CcSEcCtD
Prochlorperazine—Angioedema—Prednisone—ankylosing spondylitis	0.000128	0.00263	CcSEcCtD
Prochlorperazine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000127	0.00261	CcSEcCtD
Prochlorperazine—Urticaria—Prednisolone—ankylosing spondylitis	0.000125	0.00257	CcSEcCtD
Prochlorperazine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000123	0.00252	CcSEcCtD
Prochlorperazine—Hypotension—Betamethasone—ankylosing spondylitis	0.000123	0.00252	CcSEcCtD
Prochlorperazine—Convulsion—Prednisone—ankylosing spondylitis	0.000122	0.00249	CcSEcCtD
Prochlorperazine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000119	0.00244	CcSEcCtD
Prochlorperazine—Insomnia—Betamethasone—ankylosing spondylitis	0.000119	0.00244	CcSEcCtD
Prochlorperazine—Erythema—Methotrexate—ankylosing spondylitis	0.000117	0.00241	CcSEcCtD
Prochlorperazine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000116	0.00238	CcSEcCtD
Prochlorperazine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000115	0.00236	CcSEcCtD
Prochlorperazine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000115	0.00236	CcSEcCtD
Prochlorperazine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000115	0.00235	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000115	0.00235	CcSEcCtD
Prochlorperazine—Oedema—Prednisone—ankylosing spondylitis	0.000115	0.00235	CcSEcCtD
Prochlorperazine—Infection—Prednisone—ankylosing spondylitis	0.000114	0.00233	CcSEcCtD
Prochlorperazine—Skin disorder—Prednisone—ankylosing spondylitis	0.000111	0.00228	CcSEcCtD
Prochlorperazine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000111	0.00227	CcSEcCtD
Prochlorperazine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000107	0.00219	CcSEcCtD
Prochlorperazine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000107	0.00219	CcSEcCtD
Prochlorperazine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000105	0.00215	CcSEcCtD
Prochlorperazine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000104	0.00214	CcSEcCtD
Prochlorperazine—Urticaria—Betamethasone—ankylosing spondylitis	0.000104	0.00214	CcSEcCtD
Prochlorperazine—Dizziness—Prednisolone—ankylosing spondylitis	0.000104	0.00214	CcSEcCtD
Prochlorperazine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000104	0.00213	CcSEcCtD
Prochlorperazine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000104	0.00213	CcSEcCtD
Prochlorperazine—Insomnia—Prednisone—ankylosing spondylitis	0.000104	0.00213	CcSEcCtD
Prochlorperazine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000103	0.0021	CcSEcCtD
Prochlorperazine—Cough—Methotrexate—ankylosing spondylitis	0.000102	0.0021	CcSEcCtD
Prochlorperazine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000102	0.0021	CcSEcCtD
Prochlorperazine—Convulsion—Methotrexate—ankylosing spondylitis	0.000102	0.00209	CcSEcCtD
Prochlorperazine—Rash—Prednisolone—ankylosing spondylitis	9.94e-05	0.00204	CcSEcCtD
Prochlorperazine—Dermatitis—Prednisolone—ankylosing spondylitis	9.93e-05	0.00204	CcSEcCtD
Prochlorperazine—Headache—Prednisolone—ankylosing spondylitis	9.87e-05	0.00203	CcSEcCtD
Prochlorperazine—Constipation—Prednisone—ankylosing spondylitis	9.79e-05	0.00201	CcSEcCtD
Prochlorperazine—Dizziness—Triamcinolone—ankylosing spondylitis	9.58e-05	0.00197	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	9.57e-05	0.00196	CcSEcCtD
Prochlorperazine—Dizziness—Methylprednisolone—ankylosing spondylitis	9.56e-05	0.00196	CcSEcCtD
Prochlorperazine—Infection—Methotrexate—ankylosing spondylitis	9.51e-05	0.00195	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	9.37e-05	0.00192	CcSEcCtD
Prochlorperazine—Pruritus—Dexamethasone—ankylosing spondylitis	9.3e-05	0.00191	CcSEcCtD
Prochlorperazine—Pruritus—Betamethasone—ankylosing spondylitis	9.3e-05	0.00191	CcSEcCtD
Prochlorperazine—Skin disorder—Methotrexate—ankylosing spondylitis	9.3e-05	0.00191	CcSEcCtD
Prochlorperazine—Rash—Triamcinolone—ankylosing spondylitis	9.14e-05	0.00188	CcSEcCtD
Prochlorperazine—Dermatitis—Triamcinolone—ankylosing spondylitis	9.13e-05	0.00187	CcSEcCtD
Prochlorperazine—Rash—Methylprednisolone—ankylosing spondylitis	9.12e-05	0.00187	CcSEcCtD
Prochlorperazine—Dermatitis—Methylprednisolone—ankylosing spondylitis	9.11e-05	0.00187	CcSEcCtD
Prochlorperazine—Urticaria—Prednisone—ankylosing spondylitis	9.1e-05	0.00187	CcSEcCtD
Prochlorperazine—Headache—Triamcinolone—ankylosing spondylitis	9.08e-05	0.00186	CcSEcCtD
Prochlorperazine—Headache—Methylprednisolone—ankylosing spondylitis	9.06e-05	0.00186	CcSEcCtD
Prochlorperazine—Body temperature increased—Prednisone—ankylosing spondylitis	9.05e-05	0.00186	CcSEcCtD
Prochlorperazine—Hypotension—Methotrexate—ankylosing spondylitis	8.94e-05	0.00184	CcSEcCtD
Prochlorperazine—Dizziness—Betamethasone—ankylosing spondylitis	8.7e-05	0.00178	CcSEcCtD
Prochlorperazine—Dizziness—Dexamethasone—ankylosing spondylitis	8.7e-05	0.00178	CcSEcCtD
Prochlorperazine—Insomnia—Methotrexate—ankylosing spondylitis	8.66e-05	0.00178	CcSEcCtD
Prochlorperazine—Dyspnoea—Methotrexate—ankylosing spondylitis	8.53e-05	0.00175	CcSEcCtD
Prochlorperazine—Somnolence—Methotrexate—ankylosing spondylitis	8.51e-05	0.00175	CcSEcCtD
Prochlorperazine—Hypersensitivity—Prednisone—ankylosing spondylitis	8.44e-05	0.00173	CcSEcCtD
Prochlorperazine—Rash—Dexamethasone—ankylosing spondylitis	8.29e-05	0.0017	CcSEcCtD
Prochlorperazine—Rash—Betamethasone—ankylosing spondylitis	8.29e-05	0.0017	CcSEcCtD
Prochlorperazine—Dermatitis—Betamethasone—ankylosing spondylitis	8.28e-05	0.0017	CcSEcCtD
Prochlorperazine—Dermatitis—Dexamethasone—ankylosing spondylitis	8.28e-05	0.0017	CcSEcCtD
Prochlorperazine—Headache—Betamethasone—ankylosing spondylitis	8.24e-05	0.00169	CcSEcCtD
Prochlorperazine—Headache—Dexamethasone—ankylosing spondylitis	8.24e-05	0.00169	CcSEcCtD
Prochlorperazine—Pruritus—Prednisone—ankylosing spondylitis	8.1e-05	0.00166	CcSEcCtD
Prochlorperazine—Urticaria—Methotrexate—ankylosing spondylitis	7.6e-05	0.00156	CcSEcCtD
Prochlorperazine—Dizziness—Prednisone—ankylosing spondylitis	7.57e-05	0.00155	CcSEcCtD
Prochlorperazine—Body temperature increased—Methotrexate—ankylosing spondylitis	7.57e-05	0.00155	CcSEcCtD
Prochlorperazine—Rash—Prednisone—ankylosing spondylitis	7.22e-05	0.00148	CcSEcCtD
Prochlorperazine—Dermatitis—Prednisone—ankylosing spondylitis	7.21e-05	0.00148	CcSEcCtD
Prochlorperazine—Headache—Prednisone—ankylosing spondylitis	7.18e-05	0.00147	CcSEcCtD
Prochlorperazine—Hypersensitivity—Methotrexate—ankylosing spondylitis	7.05e-05	0.00145	CcSEcCtD
Prochlorperazine—Pruritus—Methotrexate—ankylosing spondylitis	6.77e-05	0.00139	CcSEcCtD
Prochlorperazine—Dizziness—Methotrexate—ankylosing spondylitis	6.33e-05	0.0013	CcSEcCtD
Prochlorperazine—Rash—Methotrexate—ankylosing spondylitis	6.04e-05	0.00124	CcSEcCtD
Prochlorperazine—Dermatitis—Methotrexate—ankylosing spondylitis	6.03e-05	0.00124	CcSEcCtD
Prochlorperazine—Headache—Methotrexate—ankylosing spondylitis	6e-05	0.00123	CcSEcCtD
